Rekisteröidy luodaksesi hälytyksiä instrumenteille,
taloustapahtumille ja seuraamiesi kirjoittajien sisällölle
Rekisteröidy ilmaiseksi Onko sinulla jo tili? Kirjaudu
Lainaukset
Kaikki instrumenttityypit
- Kaikki instrumenttityypit
- Indeksi
- Pääoma
- ETF:t
- Varat
- Hyödyke
- Valuutat
- Krypto
- Joukkov.
- Sertifikaatit
Yritä tehdä uusi haku
👁 Löydä voittavat osakkeet ammattilaisen tavoin tekoälyä hyödyntävien oivallusten ansiosta. Cyber Monday -tarjous päättyy pian!
HYÖDYNNÄ TARJOUS
Blackrock Global Funds - World Healthscience Fund E2 (0P0000VHO7)
Lisää salkkuun / Poista salkusta
Lisää salkkuun
56,240
-0,210
-0,37%
20/12 - Suljettu. Valuutta EUR
Tyyppi:
Rahasto
Markkinat:
Luxemburg
Liikkeeseenlaskija:
BlackRock (Luxembourg) SA
ISIN:
LU0171309270
Omaisuusluokka:
Osake
- Morningstar-luokitus:
- Pääoma yhteensä: 2,09B
BlackRock Global Funds - World Healthscience Fund
56,240
-0,210
-0,37%
0P0000VHO7 - yleiskatsaus
Tältä sivulta löytyy syväluotaava Blackrock Global Funds - World Healthscience Fund E2-profiili. Saat lisätietoja 0P0000VHO7-avainjohtajista, -kokonaisvaroista, -sijoitusstrategiasta ja -yhteystietoista.
Kategoria
Pääoma yhteensä
2,09B
Kulut
2,31%
Voimaantulopäivämäärä
06.04.2001
Yhteystiedot
Osoite
35 A, avenue J.F. Kennedy,
Luxembourg, L-1855
Luxembourg
Luxembourg, L-1855
Luxembourg
Puhelin
+44 20 77433000
Faksi
Amsterdam
Verkko
www.blackrock.com
Ylin johto
| Nimi | Otsikko | Vuodesta | Saakka |
|---|---|---|---|
| Xiang Liu | Director | 2020 | now |
| Elämäkerta | Xiang Liu, PhD, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the medical devices & supplies sector. Prior to joining BlackRock in 2008, Mr. Liu was a partner and biotech analyst at Mehta Partners. From 2002 to 2005, he was a Director in the corporate development department at Cubist Pharmaceuticals. Mr. Liu began his investment career in 2000 at the Boston Consulting Group as a Healthcare consultant. Mr. Liu earned a BS degree in Chemistry from the University of Science & Technology, China in 1993, a PhD degree in Chemistry from Yale University in 1997, and a MBA degree in finance, strategy, and accounting from the University of Chicago in 2000. | ||
| Erin Xie | Managing Director | 2011 | now |
| Elämäkerta | Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock’s Active Equity Group. She is the lead portfolio manager for the Health Sciences equity portfolios. Ms. Xie's service with the firm dates back to 2001, including her years with State Street Research & Management (SSRM), which merged with BlackRock in 2005. At SSRM, she was a Senior Vice President and portfolio manager responsible for managing the State Street Health Sciences Fund. Prior to joining State Street Research in 2001, Ms. Xie was a research associate with Sanford Bernstein covering the pharmaceutical industry from 1999. From 1994 until 1997, she was a post doctoral research scientist at Columbia University. Ms. Xie earned a BS degree in chemistry from Beijing University in 1988, a PhD degree in Biochemistry from the University of California, Los Angeles, in 1993 and a MBA degree from the Massachusetts Institute of Technology Sloan School of Management in 1999. | ||
| Jeff Lee | - | 2020 | 2023 |
| Elämäkerta | Jeffrey Lee, Director, is a member of the Health Sciences team, part of BlackRock’s Active Equity Group. He is co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the healthcare providers and services sector. Prior to joining BlackRock in 2011, Mr. Lee was a member of the healthcare investment team at Duquesne Capital Management where he covered provider and service companies. From 2006 to 2008, Mr. Lee was an healthcare private equity associate at Altaris Capital Partners where he sourced and analyzed equity transactions for public and private healthcare companies. Prior to 2006, Mr. Lee was an analyst at Citigroup within the healthcare finance and investment banking group where he valued and helped structured financing for managed care providers, hospital companies and other large healthcare systems. Mr. Lee earned a BA degree in economics, cum laude, from Princeton University in 2004. | ||
| Thomas P. Callan | Managing Director | 2011 | 2017 |
| Elämäkerta | Thomas P. Callan, CFA, Managing Director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He oversees the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. In addition, Mr. Callan is a member of BlackRock's Leadership Committee. Mr. Callan's service with the firm dates back to 1988, including his years with PNC Asset Management Group, which was integrated with BlackRock in 1998. He started as a health care analyst for PNC's mutual fund group and later served as an international equity analyst. Mr. Callan began his investment career at PNC Bank as a personal trust portfolio manager in 1988. Mr. Callan earned a BA degree in economics, with honors, from Boston College in 1981. | ||
| Bob Hodgson | - | 2005 | 2011 |
Kirjoita ajatuksiasi kohteesta Blackrock Global Funds - World Healthscience Fund E2
Haluatko varmasti poistaa tämän graafin?
Poista Peruuta
Korvaa liitteenä oleva graafi uudella graafilla?
Korvaa Peruuta
Ohjeita kommentoimiseen
Lisää graafi kommenttiin
Vahvista esto
Haluatko varmasti estää käyttäjän %USER_NAME%?
Toimiessasi näin sinä ja %USER_NAME% ette voi nähdä toistenne Investing.com-julkaisuja.
Käyttäjän %USER_NAME% lisääminen estoluetteloosi onnistui
Koska olet juuri poistanut eston tämän henkilön kohdalla, sinun täytyy odottaa 48 tuntia ennen estämisen uusimista.
Raportoi tämä kommentti
Mielestäni tämä kommentti on:
Kommentti merkitty
Kiitos!
Raporttisi on lähetetty moderaattoreidemme tarkastettavaksi